Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Clinical trial NCT01818076 · TERMINATED
Trial details
- NCT number
- NCT01818076
- Sponsor
- Revance Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2013-07-01
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.